Change in Choroidal Thickness After Intravitreal Aflibercept in Pretreated and Treatment-Naive Eyes for Neovascular Age-Related Macular Degeneration

British Journal of Ophthalmology - United Kingdom
doi 10.1136/bjophthalmol-2015-306636
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Peripapillary Choroidal Thickness After Intravitreal Ranibizumab Injections in Eyes With Neovascular Age-Related Macular Degeneration

BMC Ophthalmology
MedicineOphthalmology
2016English

Aflibercept for Neovascular Age-Related Macular Degeneration

Cochrane Database of Systematic Reviews
2016English

Aflibercept Improves Outcome in Eyes With Poor Vision From Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica
MedicineOphthalmology
2016English

Choroidal Blood Flow After the First Intravitreal Ranibizumab Injection in Neovascular Age-Related Macular Degeneration Patients

Acta Ophthalmologica
MedicineOphthalmology
2018English

Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Scientific Reports
Multidisciplinary
2019English

Non-Responsiveness to Intravitreal Aflibercept Treatment in Neovascular Age-Related Macular Degeneration: Implications of Serous Pigment Epithelial Detachment

Scientific Reports
Multidisciplinary
2016English

One Year Effectiveness Study of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: A Meta-Analysis

Acta Ophthalmologica
MedicineOphthalmology
2018English

Cost-Effectiveness of Intravitreal Aflibercept Injection (IAI) in Treating Neovascular Age-Related Macular Degeneration in the US

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Full Thickness Macular Hole Case After Intravitreal Aflibercept Treatment

BMC Ophthalmology
MedicineOphthalmology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy